Entering the US pharma market with LL would be a HUGE win for Samsung. And there is no need for them to buyout the Company. They could simply partner with Cytodyn and participate in revenue sharing in all the different indicators LL succeeds in. With Samsung's deep pockets, LL would have the resources to take on BP. I love this idea.